Pages that link to "Q40664994"
Jump to navigation
Jump to search
The following pages link to Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study (Q40664994):
Displaying 50 items.
- Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease--a Mendelian Randomisation study (Q21090089) (← links)
- Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17 (Q21145265) (← links)
- Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association (Q22306356) (← links)
- Risk scoring for the primary prevention of cardiovascular disease (Q24186884) (← links)
- Risk scoring for the primary prevention of cardiovascular disease (Q24198953) (← links)
- Risk scoring for the primary prevention of cardiovascular disease (Q24242166) (← links)
- Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip (Q24657931) (← links)
- Can non-physician health-care workers assess and manage cardiovascular risk in primary care? (Q24657952) (← links)
- Cardiovascular risk assessment in rheumatoid arthritis - controversies and the new approach (Q26738461) (← links)
- Aortic Root Calcification: A Possible Imaging Biomarker of Coronary Atherosclerosis (Q26747989) (← links)
- Use of fibrates in the metabolic syndrome: A review (Q26765234) (← links)
- Genetics of coronary artery disease and myocardial infarction (Q26769994) (← links)
- Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling (Q26775003) (← links)
- Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population (Q26777077) (← links)
- Classical and novel biomarkers for cardiovascular risk prediction in the United States (Q26824026) (← links)
- Residual macrovascular risk in 2013: what have we learned? (Q26996039) (← links)
- Clinical prediction rules in practice: review of clinical guidelines and survey of GPs (Q27002373) (← links)
- Evaluation of the Families SHARE workbook: an educational tool outlining disease risk and healthy guidelines to reduce risk of heart disease, diabetes, breast cancer and colorectal cancer (Q27310710) (← links)
- Overview of guidelines for the management of dyslipidemia: EU perspectives (Q28069411) (← links)
- Diabetes and Hypertension Consistently Predict the Presence and Extent of Coronary Artery Calcification in Symptomatic Patients: A Systematic Review and Meta-Analysis (Q28080083) (← links)
- Primary prevention of coronary heart disease? What is cost effective in the clinical practice? (Q28192987) (← links)
- Cardiovascular secondary prevention (Q28200591) (← links)
- Premature coronary artery disease in Indians and its associated risk factors (Q28219336) (← links)
- Measuring allostatic load in the workforce: a systematic review (Q28387999) (← links)
- Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited) (Q28602638) (← links)
- Time-efficient black blood RCA wall imaging at 3T using improved motion sensitized driven equilibrium (iMSDE): feasibility and reproducibility (Q28743647) (← links)
- Distribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian Sentinel Surveillance Study population (cross-sectional survey results) (Q28744014) (← links)
- Heart disease and stroke statistics--2011 update: a report from the American Heart Association (Q29547236) (← links)
- Heart disease and stroke statistics--2014 update: a report from the American Heart Association (Q29547691) (← links)
- Heart disease and stroke statistics--2012 update: a report from the American Heart Association (Q29547909) (← links)
- The metabolic syndrome (Q29616309) (← links)
- Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment (Q30234498) (← links)
- Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women? (Q30234825) (← links)
- Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association (Q30501645) (← links)
- Should health insurers target prevention of cardiovascular disease? A cost-effectiveness analysis of an individualised programme in Germany based on routine data (Q30831810) (← links)
- Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data (Q30848584) (← links)
- The effectiveness of the cardiovascular disease prevention programme 'KardioPro' initiated by a German sickness fund: a time-to-event analysis of routine data (Q30875843) (← links)
- The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases (Q31129827) (← links)
- Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe. (Q31139249) (← links)
- Comparison of self-perceived cardiovascular disease risk among smokers with Framingham and PROCAM scores: a cross-sectional analysis of baseline data from a randomised controlled trial (Q31153388) (← links)
- Presence and extent of cardiac computed tomography angiography defined coronary artery disease in patients presenting with syncope (Q33168435) (← links)
- Imaging of vessels supplying the brain (Q33168797) (← links)
- How artificial intelligence tools can be used to assess individual patient risk in cardiovascular disease: problems with the current methods (Q33242092) (← links)
- Relative risk for cardiovascular atherosclerotic events after smoking cessation: 6-9 years excess risk in individuals with familial hypercholesterolemia (Q33261040) (← links)
- Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study (Q33307043) (← links)
- Individual assessment of arteriosclerosis by empiric clinical profiling (Q33307524) (← links)
- Dyslipidemia in primary care--prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). (Q33376862) (← links)
- Construction of an odds model of coronary heart disease using published information: the Cardiovascular Health Improvement Model (CHIME) (Q33381870) (← links)
- Red blood cell fatty acid patterns and acute coronary syndrome (Q33440563) (← links)
- Mortality risk prediction by an insurance company and long-term follow-up of 62,000 men (Q33440570) (← links)